← All indications

Protein-Losing Enteropathies

Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIS; WHIPPLE'S DISEASE; and NEOPLASMS of the SMALL INTESTINE.

Drugs by status

Approved for this indication (1)

pozelimab

Phase 4 trials (1)

budesonide

Phase 2 trials (2)

Phase 1 trials (1)

2-o, 3-o desulfated heparin

Other trials (2)

Organizations

Organization Involved with Phase 3 Indications (1)

Regeneron

Organization Involved with Phase 2 Indications (1)

University of Michigan

Organization Involved with Phase 1 Indications (1)

Cantex Pharmaceuticals